Company intelligence / Profile preview

Celentyx

Birmingham, England, United Kingdom
Ownership
Private
Employees
~12
Development stage
Other
01

Overview

Celentyx is a private UK-based immunology-focused contract research organization that provides bespoke in vitro assay services to pharmaceutical and biotechnology clients. The company specializes in human primary cell and patient-sample based research supporting immuno-oncology, autoimmunity and inflammation, fibrosis, neuroinflammation, and related areas. Its offerings include functional immune-cell assays, tumour microenvironment and tumour-cell killing assays, cytokine and biomarker profiling, CyTOF, flow cytometry, Luminex, imaging, and custom assay development. Celentyx positions itself as a translational immunology partner that helps clients evaluate drug effects in relevant human systems rather than as a developer of its own therapeutics. The business appears active, privately held, and centered on service revenue rather than a traditional internal drug pipeline.

Therapeutic areas
ImmunologyOtherNeurologyInfectious DiseasesOncology
Modalities
Small moleculeMonoclonal antibodyCytokineBiologic
Industry
Drug Discovery Services
02

Partnerships

MRC Centre for Immune RegulationCentre for Translational Inflammation ResearchQueen Elizabeth Hospital Birmingham

Beyond the preview

Go deeper on Celentyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celentyx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call